MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01256nam a22002657i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-GaU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250630115443.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250630s2023 nyuado|fr|||| 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781639279753 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-GaU |
| Transcribing agency |
EG-GaU |
| Modifying agency |
EG-GaU |
| Description conventions |
rda |
| Language of cataloging |
eng |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
615.1 |
| Item number |
s.o.c |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Settle, Octavia, |
| Relator term |
editor. |
| 9 (RLIN) |
59870 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Chemistry and pharmacology of anticancer drugs / |
| Statement of responsibility, etc. |
edited by Octavia Settle. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
American Medical Publishers, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2023. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
252 pages ; |
| Dimensions |
27 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| Media type code |
n |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| Carrier type code |
nc |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
This book compiles chapters on the emerging trends in anticancer drugs, focusing on antineoplastic agents that treat various cancers by alkylating proteins, RNA, and DNA. It includes research and studies from experts worldwide and is an invaluable resource for cancer researchers, medicinal chemists, and biomedical scientists involved in developing new anticancer therapies.<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Antineoplastic agents |
| 9 (RLIN) |
519 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| 9 (RLIN) |
59871 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cancer drugs |
| 9 (RLIN) |
59872 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |